? 1. The heart stent was reduced from thirteen thousand to 700 yuan because of national procurement.
? 165438+1October 5,? National team? Heart stents in the field of high-value medical consumables were officially released. Because of its large clinical dosage and high price, it has become the first batch of consumables purchased centrally in China. The centralized procurement of coronary artery branches organized by the state is an important measure to control the false high price and circulation chaos of high-value consumables, a key link to comprehensively deepen the centralized procurement reform in the medical field, and a pragmatic move for the people and the people.
? 2. The heart stent was reduced from thirteen thousand to 700 yuan, which lightened the burden for patients.
? Due to the continuous development of economy and society, the state pays more and more attention to the quality of life of the masses. Purchasing with quantity has greatly reduced the treatment cost of the masses. Because the heart stent alone costs 13000 yuan, and the drugs needed for a long time are not trivial for an ordinary family, but the reduction of heart stent from 13000 yuan to 700 yuan has alleviated the burden of patients to some extent, and the related drugs will also decrease with development.
? 3. The number of heart stents dropped from 1.3 million to 700 yuan, bringing more people back to life.
? Many people see that because of family conditions, a heart stent alone costs 1.3 million, and may give up treatment. This time, the heart stent dropped to 700 yuan, which made the patients see hope. For ordinary patients, the price reduction of cardiac stents is feasible for them. They not only have to endure illness, but also bear the pressure from family economy. This price cut gave hope to patients. At the same time, it also greatly reduces the burden and pressure of many patients' families.